Holen Sie sich die Stockscreener-App
20.79
0.10%
-0.02
Handel nachbörslich:
20.72
-0.07
-0.34%
Schlusskurs vom Vortag:
$20.81
Offen:
$20.77
24-Stunden-Volumen:
2.95M
Relative Volume:
0.41
Marktkapitalisierung:
$14.34B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
65.21
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
-2.90%
1M Leistung:
-4.02%
6M Leistung:
+24.49%
1J Leistung:
+22.01%
1-Tages-Spanne:
$20.70
$20.89
1-Wochen-Bereich:
$20.46
$21.30
52-Wochen-Spanne:
$15.70
$22.95
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
20.79 | 14.25B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
235.52 | 165.93B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
91.52 | 45.66B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
46.53 | 13.90B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
54.31 | 10.14B | 2.37B | 101.67M | 169.19M | 0.5775 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
Healthpeak Properties (NYSE:DOC): Is the Valuation Story Shifting? - Kalkine Media
Healthpeak Properties (NYSE:DOC): What Changes Next? - Kalkine Media
Healthpeak Properties (NYSE:DOC) Given New $24.00 Price Target at Robert W. Baird - MarketBeat
DOC Maintained by Baird -- Price Target Raised to $24.00 - GuruFocus
Baird Adjusts Price Target on Healthpeak Properties to $24 From $21, Keeps Outperform Rating - marketscreener.com
Healthpeak Properties (DOC) Q2 2026 Earnings Call Transcript - AOL.com
DOC Maintains by Citigroup -- Price Target Raised to $22.00 - GuruFocus
Healthpeak Properties Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Healthpeak Properties (NYSE:DOC): What Is Driving Fresh Attention? - kalkinemedia.com
Citigroup Adjusts Price Target on Healthpeak Properties to $22 From $20, Keeps Neutral Rating - marketscreener.com
BNP Paribas Adjusts Price Target on Healthpeak Properties to $23 From $22, Keeps Outperform Rating - marketscreener.com
Healthpeak Properties, Inc. (NYSE:DOC) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Should Healthpeak’s Stronger Q2 Earnings and Higher 2026 EPS Guidance Require Action From DOC Investors? - webull.com
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is the Options Market Predicting a Spike in Healthpeak Properties Stock? - Zacks Investment Research
DOC Maintained by RBC Capital -- Price Target Raised to $24.00 - GuruFocus
Royal Bank Of Canada Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price - MarketBeat
RBC Capital Adjusts PT on Healthpeak Properties to $24 From $21, Keeps Outperform Rating - marketscreener.com
Enterprise value to EBIT forward of Healthpeak Properties, Inc. – HAM:HC5 - TradingView
Healthpeak Properties (DOC) On Raised Guidance And The Undervalued Narrative - Yahoo Finance
Healthpeak Properties (DOC) Stock Looks Below Fair Value Despite Rich Earnings - Yahoo Finance
Pacer Advisors Inc. Purchases 47,729 Shares of Healthpeak Properties, Inc. $DOC - MarketBeat
Should Healthpeak’s Raised 2026 EPS Guidance and Profitability Shift Require Action From Healthpeak Properties (DOC) Investors? - Yahoo Finance
Evercore Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $23 - Moomoo
Healthpeak Properties Q2 Earnings Call Highlights - MarketBeat
Healthpeak Properties Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties: The Market Still Underestimates Its Recovery Potential (NYSE:DOC) - Seeking Alpha
State Street reports 6.4% stake in Healthpeak Properties (NYSE: DOC) - Stock Titan
Pensionfund PDN's Healthpeak Properties Inc(DOC) Holding History - GuruFocus
A Look at Healthpeak Properties Inc (DOC) After 3.2% Decline -- GF Value $19.71 vs Price $21.10 - GuruFocus
Cantor Fitzgerald Boosts Healthpeak Properties (NYSE:DOC) Price Target to $23.00 - marketbeat.com
Healthpeak Properties Inc (DOC) (Q2 2026) Earnings Call Highlights: Strong Leasing Momentum and ... - Yahoo Finance
Healthpeak Properties Reports Strong Q2 Results, Capital Actions - The Globe and Mail
Healthpeak Properties Inc (DOC) (Q2 2026) Earnings Call Highligh - GuruFocus
Healthpeak Properties 2Q 2026: Revenue $771.6M, EPS $0.08— 10-Q Summary - TradingView
Healthpeak Properties (NYSE: DOC) details Janus Living IPO and Brookfield JV - Stock Titan
DOC Q2 FFO Beat Estimates on Leasing & Senior Housing Gains - TradingView
Earnings call transcript: Healthpeak beats Q2 2026 estimates and raises outlook - Investing.com
Is Wall Street Bullish or Bearish on Healthpeak Properties Stock? - barchart.com
Healthpeak Properties, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Healthpeak Properties: A Well-Covered 5.6% Yield, But Life Science Recovery Remains Key - Seeking Alpha
Healthpeak Properties, Inc. $DOC Shares Acquired by Bank of America Corp DE - MarketBeat
Healthpeak Properties, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Healthpeak Properties earnings beat by $0.06, revenue topped estimates - Investing.com
Healthpeak Properties (NYSE:DOC) Announces Quarterly Earnings Results - MarketBeat
Healthpeak (DOC) Surpasses Q2 FFO and Revenue Estimates - Yahoo Finance
Healthpeak Q2 earnings beat as occupancy increases from prior quarter (DOC:NYSE) - Seeking Alpha
Is Healthpeak Properties Inc (DOC) Fairly Valued After Q2 Earnin - GuruFocus
(DOC) Healthpeak Properties Now Expects 2026 Adjusted FFO Range $1.73-$1.77, vs. FactSet Est of $1.74 - marketscreener.com
Healthpeak Properties Q2 Adjusted FFO Flat, Revenue Rises - Yahoo Finance
Earnings Flash (DOC) Healthpeak Properties, Inc. Posts Q2 FFO $0.46 per Share, vs. FactSet Est of $0.43 - marketscreener.com
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):